The health gains seen in the trials, from lower blood sugar to improved cholesterol, connect directly to lower long-term risks for heart disease, diabetes complications, and other chronic illnesses
Findings from an exposure-response analysis of cemsidomide in relapsed/refractory multiple myeloma (r/r MM) indicate an increased anti-myeloma effect at higher exposures and a clinically manageable exposure-safety relationship, supporting the risk-benefit analysis in patients with advanced late-stage r/r MM
Underlying various diseases, such as neurodegenerative disorders, diabetes, cancer, atherosclerosis, and IBD, the ER UPR has gained enormous attention during the past years (8)
Discouraged, I talked to my doctor, who prescribed a GLP-1 medication to kick-start my progress
For example, the PIONEER 6 trial, conducted from January to August 2017, reported an average increase of 4 beats per minute in patients taking oral semaglutide